Cell Microsystems
PrivateLast Round
Series B
Aug 23, 2023
Total Funding Raised
$27.73M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cell Microsystems operates in Healthcare & Life Sciences and is based in Durham, North Carolina. Its latest recorded funding round was a Series B round in August 2023.
Cell Microsystems is a biotechnology company that develops, manufactures, and markets products for single-cell biology, including its CellRaft AIR® System for cell engineering, culture, and analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cell Microsystems Comparables
Compare Cell Microsystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoCellect Biomedical | 81% | |
| Deepcell | 81% | |
| Bruker | 78% |
For institutional investors. Book with your work email.
Cell Microsystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 23, 2023 | ||||
| Series A | Nov 15, 2021 | ||||
| Debt | Sep 1, 2020 | ||||
| Convertible Debt | Feb 21, 2019 |
For institutional investors. Book with your work email.
Cell Microsystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Telegraph Hill Partners | Series B, Series A |
| North Carolina Biotechnology Center | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 32% MoM.
- May 4, 2025
Monthly visitors grew 200% MoM, reaching 8.4K.
For institutional investors. Book with your work email.
Cell Microsystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cell Microsystems's valuation, stock price, and market status.
Is Cell Microsystems a public or private company?
Cell Microsystems is a private company.
What is the current stock price of Cell Microsystems?
Cell Microsystems is a private company, so its shares have no public market price. Caplight tracks Cell Microsystems's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cell Microsystems worth (valuation)?
Valuation information for Cell Microsystems is not publicly available.
Can I buy Cell Microsystems stock?
Cell Microsystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cell Microsystems's last funding round?
Cell Microsystems's most recent funding round was Series B on August 23, 2023.
Who are the main investors in Cell Microsystems?
Key investors in Cell Microsystems include Telegraph Hill Partners.
Will Cell Microsystems IPO soon?
No public IPO plans have been announced for Cell Microsystems.
How can I track Cell Microsystems secondary market activity?
Caplight tracks bids, offers, and trades in Cell Microsystems's shares on secondary markets.